Page last updated: 2024-10-31

metoprolol and Thoracic Neoplasms

metoprolol has been researched along with Thoracic Neoplasms in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.

Research Excerpts

ExcerptRelevanceReference
" We report a case of a patient receiving the selective beta(1)-adrenergic antagonist, metoprolol, immediately before surgery that was associated with severe hypoglycemia."7.72Hypoglycemia associated with preoperative metoprolol administration. ( Brown, DR; Brown, MJ, 2004)
" We report a case of a patient receiving the selective beta(1)-adrenergic antagonist, metoprolol, immediately before surgery that was associated with severe hypoglycemia."3.72Hypoglycemia associated with preoperative metoprolol administration. ( Brown, DR; Brown, MJ, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, DR1
Brown, MJ1

Other Studies

1 other study available for metoprolol and Thoracic Neoplasms

ArticleYear
Hypoglycemia associated with preoperative metoprolol administration.
    Anesthesia and analgesia, 2004, Volume: 99, Issue:5

    Topics: Adrenergic beta-Antagonists; Blood Glucose; Female; Glucose; Humans; Hypoglycemia; Metoprolol; Middl

2004